Insulet
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average and near the bottom of the universe on momentum.
- Signal has read STRONG SELL for 8 months.
- Its last 3 Sell calls were followed by a 34% average decline over the next quarter.
- Recent price momentum is -33.4% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 7.7% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation B-
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 21.8x | Better than 37% |
| Forward P/E | 21.1x | Better than 33% |
| Price / Sales | 3.3x | Better than 37% |
| P/E vs own 5-yr range | 6th pctl | Better than 94% |
Growth A+
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 27.5% | Better than 89% |
| Net income CAGR (3Y) | 277.3% | Better than 99% |
Profitability A-
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 71.6% | Better than 84% |
| Operating margin | 17.5% | Better than 71% |
| Net margin | 9.1% | Better than 57% |
| Return on equity | 18.1% | Better than 75% |
| Return on invested capital | 10.5% | Better than 70% |
Momentum D+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -10.1% | Better than 50% |
| 6-month return | -14.0% | Better than 34% |
| 12-month return (ex latest month) | -55.0% | Better than 2% |
| Distance below 52-week high | 61.1% | Better than 10% |
Financial Health B+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 2.8x | Better than 71% |
| Debt to assets | 29.8% | Better than 42% |
| Interest coverage | 6.7x | Better than 64% |
| Free cash flow / net income | 141.6% | Better than 62% |
Analyst View C
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 42.9% | Better than 23% |
| Upside to average target | 33.1% | Better than 52% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 137.23
- Open
- 134.97
- Day range
- 132.38 - 140.47
- Avg price
- 135.19
- Volume
- 1.80M
- Turnover
- 243.88M
- Turnover ratei
- 3.02%
- Volume ratioi
- 1.05
- Amplitudei
- 5.90%
- 52-week rangei
- 126.40 - 342.13
Valuation
- P/Ei
- 38.27
- P/E (TTM)i
- 21.76
- P/Bi
- 5.85
- EPSi
- 3.48
- Book value / shi
- 22.76
- Net profit
- 241.41M
- Net assets
- 1.58B
Share structure
- Market cap
- 9.24B
- Float capi
- 7.95B
- Shares out
- 69.37M
- Float sharesi
- 59.67M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
61.1% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-5.99M net over the window
Short interest
- Shares short
- 5.33M
- % of floati
- 7.68%
- Days to coveri
- 4.25
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Insulet (PODD)?
Insulet last traded at 133.17. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Insulet's market cap?
About 9.24B.
What is the P/E ratio of Insulet?
The trailing twelve-month P/E is 21.76, below its own 5-year average of 1,814.54 — toward the bottom of its historical range (6.14% percentile). See the Valuation tab for the full history.
Does Insulet pay a dividend?
Insulet does not currently pay a regular dividend.
Is Insulet a buy according to analysts?
The consensus of 14 analysts is a Buy rating, with an average 12-month price target of 177.23, which implies 33.1% upside from the current price. This is not investment advice.
What is Insulet's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Insulet a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.
Quote time 2026-11-20 20:01:08 · For reference only, not investment advice and not tailored to your situation.
Insulet discussion 0 comments